IP Verse

Translate Bio competitive analysis

Latest patents of Translate Bio opposed by its competitors

Explore Translate Bio's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 9, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2858679
Jun 5, 2024Pulmonary Delivery Of Mrna To Non-Lung Target Cells1
EP3501605
Jun 28, 2023Mrna Therapy For Argininosuccinate Synthetase Deficiency1
EP2970456
May 19, 2021Methods And Compositions For Delivering Mrna Coded Antibodies4
EP3336082
Apr 15, 2020Cleavable Lipids2
EP3134506
Aug 7, 2019Methods For Purification Of Messenger Rna2
EP3318248
Apr 10, 2019Delivery Of Mrna For The Augmentation Of Proteins And Enzymes In Human Genetic Diseases2
EP2850189
Jan 23, 2019Compositions And Methods For Modulating Gene Expression1
EP3060303
Nov 14, 2018Mrna Therapy For Argininosuccinate Synthetase Deficiency1
EP3122878
Oct 24, 2018Mrna Therapy For The Treatment Of Ocular Diseases1
EP2506857
Feb 14, 2018Delivery Of Mrna For The Augmentation Of Proteins And Enzymes In Human Genetic Diseases2

Latest publications and patents of Translate Bio New

Explore the latest publications and patents granted to Translate Bio, showcasing their recent innovations and technological advancements.

Last updated on: Oct 8, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Translate Bio

EP2858679
Jun 5, 2024Pulmonary Delivery Of Mrna To Non-Lung Target CellsPatent Maintained As Amended
EP3501605
Jun 28, 2023Mrna Therapy For Argininosuccinate Synthetase DeficiencyRevoked
EP2970456
May 19, 2021Methods And Compositions For Delivering Mrna Coded AntibodiesGranted And Under Opposition
EP3336082
Apr 15, 2020Cleavable LipidsRevoked
EP3134506
Aug 7, 2019Methods For Purification Of Messenger RnaGranted And Under Opposition
EP3318248
Apr 10, 2019Delivery Of Mrna For The Augmentation Of Proteins And Enzymes In Human Genetic DiseasesRevoked
EP2850189
Jan 23, 2019Compositions And Methods For Modulating Gene ExpressionRevoked
EP3060303
Nov 14, 2018Mrna Therapy For Argininosuccinate Synthetase DeficiencyRevoked
EP3122878
Oct 24, 2018Mrna Therapy For The Treatment Of Ocular DiseasesOpposition Rejected
EP2506857
Feb 14, 2018Delivery Of Mrna For The Augmentation Of Proteins And Enzymes In Human Genetic DiseasesRevoked

Latest PTAB cases involving Translate Bio

Discover the latest PTAB cases involving Translate Bio, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Translate Bio with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 9, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
TRANSLATE BIO - 16 - -
BRADY4 - - -
GLAXOSMITHKLINE29112812
WITHERS & ROGERS33 - - -